Clinical Trial Update: Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating sirolimus (Rapamune) for treatment of severe arteriovenous malformations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriovenous Malformations

Drugs mentioned

• Rapamune (sirolimus)

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Arteriovenous Malformations | Phase 2 | Status: UNKNOWN